Also, the TLR4/MyD88 signaling is implicated in the acquisition of paclitaxel resistance in ovarian cancer and MyD88 inhibition renders colon cancer cell lines susceptible to apoptosis mediated by cisplatin [15,16]. Here, MYD88 is linked to malignant colon neoplasm.